Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps by Beristain-Covarrubias, Nonantzin et al.
1 
 
Salmonella-induced thrombi in mice develop asynchronously in the spleen 1 
and liver and are not effective bacterial traps 2 
Short title:  3 
Salmonella-induced thrombi do not trap bacteria 4 
 5 
Nonantzin Beristain-Covarrubias1*, Marisol Perez-Toledo1*, Adriana Flores-Langarica1, Malou 6 
Zuidscherwoude2,4, Jessica R Hitchcock1, Will M. Channell1, Lloyd D.W. King1, Mark R. Thomas2, 7 
Ian R. Henderson3, Julie Rayes2, Steve P. Watson2,4, and Adam F. Cunningham1 8 
 9 
1Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of 10 
Birmingham, UK; 2Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, 11 
University of Birmingham, UK; 3Institute for Microbiology and Infection, College of Medical and 12 
Dental Sciences, University of Birmingham, UK; and 4Centre of Membrane Proteins and Receptors, 13 
Universities of Birmingham and Nottingham, The Midlands, UK 14 
* N.B.C. and M.P.T. contributed equally to this work. 15 
 16 
 17 
Corresponding authors:  18 
Adam F. Cunningham, 1Institute of Immunology and Immunotherapy, College of Medical and Dental 19 
Sciences, University of Birmingham, B15 2TT, UK. A.f.cunningham@bham.ac.uk. Phone: 20 
+441214144068, Fax: +441214143599 21 
Steve P. Watson, 2Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, 22 
University of Birmingham, B15 2TT, UK. S.p.watson@bham.ac.uk. Tel: +441214146514 23 
 24 
 25 
Text word count: 1192 26 
Abstract word count: 195 27 
Figures: 2 28 
Tables: 0 29 
References: 19 30 
Key words: Immunothrombosis, platelets, monocytes, inflammation, podoplanin, Salmonella 31 
 32 
 33 
 34 
 Blood First Edition Paper, prepublished online November 6, 2018; DOI 10.1182/blood-2018-08-867267
 Copyright © 2018 American Society of Hematology
For personal use only.on December 9, 2018. by guest  www.bloodjournal.orgFrom 
2 
 
Key points: 35 
• Thrombosis develops in the spleen and liver with distinct kinetics following Salmonella 36 
infection 37 
• Thrombi in the spleen and liver are not major sites of bacterial localisation 38 
Abstract  39 
Thrombosis is a frequent, life-threatening complication of systemic infection, associated with multiple 40 
organ damage. We have previously described a novel mechanism of inflammation-driven thrombosis 41 
induced by Salmonella Typhimurium infection of mice. Thrombosis in the liver develops 7 days post-42 
infection persisting after the infection resolves, and is monocytic cell-dependent. Unexpectedly, 43 
thrombosis was not prominent in the spleen at this time, despite carrying a similar bacterial burden as 44 
the liver. In this study, we show that thrombosis does occur in the spleen but with strikingly 45 
accelerated kinetics compared to the liver, being evident by 24 h and resolving rapidly thereafter. The 46 
distinct kinetics of thrombosis and bacterial burden provide a test of the hypothesis that thrombi form 47 
in healthy vessels to trap or remove bacteria from the circulation, often termed immunothrombosis. 48 
Remarkably, despite bacteria being detected throughout infected spleens and livers in the early days 49 
of infection, immunohistological analysis of tissue sections show that thrombi contain very low 50 
numbers of bacteria. In contrast, bacteria are present throughout platelet aggregates induced by 51 
Salmonella in vitro. Therefore, we show that thrombosis develops with organ-specific kinetics and 52 
challenge the universality of immunothrombosis as a mechanism to capture bacteria in vivo. 53 
Introduction 54 
The consequences of thrombosis are the leading cause of death worldwide1. Thrombosis is common 55 
after infection and can lead to organ failure and poor outcome2-5.  There are however significant gaps 56 
in our understanding of blood-borne infection-associated thrombosis, including whether it occurs at 57 
multiple sites through distinct mechanisms and/or kinetics2. Immune-driven thrombosis, broadly-58 
termed “immunothrombosis”, can occur in the presence or absence of infection. Nevertheless, when 59 
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triggered by infection, it is still unclear whether the induced thrombi capture and contain blood-borne 60 
pathogens within the vasculature as proposed6-8. 61 
We recently reported on a novel pathway of thrombosis in the liver after infection with Salmonella 62 
Typhimurium (STm), involving inflammation-driven upregulation of podoplanin on monocytic cells 63 
and activation of platelets9. A striking feature of this thrombosis is that it takes a week to develop and 64 
then persists as the bacterial burden declines. Furthermore, thrombi are largely undetectable in the 65 
spleen at this time, despite this organ being a major site of bacterial colonisation10,11. In this paper, we 66 
show that extensive thrombosis does occur in the spleen but is rapid in onset and transient, with 67 
distinct kinetics to liver. Furthermore, we show that thrombi present in either organ contain 68 
surprisingly few bacteria, despite the high bacterial burdens in the organs themselves, indicating that 69 
bacterial entrapment is not a major consequence of thrombosis after infection with STm. 70 
Study design 71 
Full details are provided in the Supplemental Material 72 
Mice and infection with STm 73 
Wild-type (WT), C57BL/6 mice (Home Office Licenses 3028/50 and P2E63AE7B) were infected 74 
intraperitoneally (i.p.) or intravenously (i.v.) with 1-5x105 attenuated SL3261 or virulent SL1344 75 
STm12,13.  76 
Immunohistology and fluorescent microscopy  77 
Cryosections were stained for immunohistochemistry (IHC) or immunofluorescence (IF)13,14 to detect 78 
CD41, CD31, fibrin/fibrinogen, Ly6G, Ly6C, F4/80, Salmonella and nuclei (DAPI; Supplemental 79 
Table 1)9.  80 
Clodronate treatment 81 
Mice were treated i.p. with either 200 μl (5 mg/ml) of clodronate or PBS liposomes 24 h before STm 82 
infection15,16 83 
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Results and Discussion 84 
Thrombosis develops with distinct kinetics in the spleen and liver 85 
Thrombosis in the liver becomes established 7 days after infection, whereas few thrombi are 86 
detectable in the spleen at this time9. In the liver, thrombosis is driven by the up-regulation of 87 
podoplanin on monocytes/macrophages, triggering activation of CLEC-2 on platelets9.  The spleen is 88 
a reservoir of monocytic cells, with high numbers of these cells present pre-infection compared to the 89 
liver, and 24 hours post-infection there were increased numbers of inflammatory splenic monocytes 90 
(Supplemental Figure S1), suggesting that thrombosis may occur at a much earlier stage in the 91 
infection. Consistent with this, we found numerous, large platelet-rich thrombi within the spleen at 24 92 
h post-infection (Figure 1A), independent of whether mice were infected i.v. or i.p. or of the virulence 93 
of the infecting strain (Figure 1B-C). Thrombi typically stained positive for citrullinated-histone H3, 94 
Ly6G+ cells and myeloperoxidase (Supplemental Figure S2). Ly6C+ and F4/80+ cells were located at 95 
the periphery of thrombi (Supplemental Figure S3). Splenic thrombosis resolved rapidly after day 1, 96 
with few thrombi detected thereafter (Figure 1D,E), often leaving the remnants of a fibrin core (Figure 97 
1 and 2A). In contrast, at these early times, thrombosis was undetectable in the liver (Figure 98 
1B,C,D,F). Moreover, thrombosis was absent in the spleens of clodronate-liposome treated mice 99 
(Figure 1G) suggesting that, like in the liver, monocytic cells are important in this process9. Therefore, 100 
systemic infection with STm can induce thrombosis in distinct sites and with distinct kinetics, likely 101 
due to the levels of tissue-resident macrophages present at the time of infection. 102 
Most thrombi induced in the spleen and liver contain limited numbers of bacteria  103 
It has been proposed that thrombus formation can trap and remove bacteria, a process sometimes 104 
known as immunothrombosis6. After platelet activation induced by STm in vitro, bacteria are present 105 
throughout the aggregate as shown in Supplemental Figure S4 and video 1. This demonstrates that 106 
bacteria can closely associate with platelets in aggregates formed in vitro. We used IHC and IF 107 
microscopy to identify the relationship between bacterial localisation and thrombi in vivo at the peak 108 
times of thrombosis in the spleen (day 1) and liver (day 7) (Figure 2A-B and Supplemental Figure 109 
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S5). A 3-dimensional reconstruction of a thrombus and proximal bacteria is shown in Supplemental 110 
Figure S6 and Supplemental Video 2. Collectively, these approaches all showed that thrombi 111 
contained a surprisingly low number of bacteria, despite their relative abundance in the surrounding 112 
tissues. Quantification of the bacteria within sections of splenic thrombi (>200 thrombi from 37 mice, 113 
3 time points evaluated) showed that no bacteria were detected in 38% of thrombus sections at day 1, 114 
and that 33% of sectioned thrombi contained 1-2 bacteria (Figure 2C). At later times, bacteria were 115 
detected at an even lower frequency within sections of splenic thrombi, with >90% of thrombi 116 
containing 0-2 bacteria at day 7 and day 21 (Figure 2C). In the liver, only ~20% of thrombi sections 117 
(>400 thrombi counted from 23 mice) contained bacteria at day 7 and this proportion was even lower 118 
(<5%) at day 21 (Figure 2D). Analysis of serial sections from the same thrombi confirmed a paucity 119 
of bacteria within individual thrombi (Supplemental Figure S7). When the bacterial burdens per organ 120 
were compared with the levels of thrombosis at days 1 to 21 post-infection, no direct relationship was 121 
found between the two, other than the necessity for infection to induce thrombosis. In the spleen, 122 
thrombosis peaks before bacterial numbers peak (Figure 2E) and falls whilst bacterial numbers are 123 
still rising, whereas in the liver thrombosis develops later and peaks when the bacterial levels are 124 
beginning to decline (Figure 2F)9,13,17.  Therefore, thrombi induced during this infection do not trap 125 
significant numbers of bacteria, regardless of the bacterial loads in the organs. This contrasts with 126 
other models of infection18,19, which used 1000-fold higher numbers of bacteria compared to here9. 127 
Thus, although STm infection can drive thrombosis, thrombi do not necessarily contribute to bacterial 128 
containment and moreover they form in different organs with distinct kinetics. These findings are 129 
important for our understanding of the consequences of infection on the haematological system since 130 
they show that the presence of equivalent levels of bacteria is not enough to induce thrombosis in an 131 
organ.  132 
Although these data show that during a single infection thrombosis can occur sequentially in multiple 133 
tissues, further work is needed to evaluate whether other systemic bacterial infections induce 134 
thrombosis with similar kinetics. Thrombi are induced by many different pathogens and although the 135 
role of thrombosis after infection remains unclear, the presumption must be that they are pathological 136 
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in some circumstances, particularly if they are large and/or embolise. Since we have shown that 137 
thrombi develop in the venous system, they may form due to differences in local infection-associated 138 
changes in blood flow and as part of altered vessel homeostasis. Perhaps the bigger clinical question is 139 
about what controls their ultimate size and what triggers thrombus resolution as this may influence 140 
whether thrombosis becomes clinically problematic. Therefore, for a known infection it may be 141 
possible to target therapeutically those organs at greatest risk of developing thrombosis at particular 142 
stages of infection. These findings deepen our understanding of the concept of immunothrombosis and 143 
shows thrombi can form as a non-canonical haemostatic response to infection-driven inflammation 144 
but not to capture bacteria.  145 
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Figure legends 200 
Figure 1. Thrombosis in the spleen and liver follows different kinetics after STm infection. (A) 201 
Frozen spleens from WT mice infected with 5x105 STm i.p were sectioned longitudinally to the hilum 202 
(≥1200μm deep) and 5-μm sections were stained by IHC. Scans of stained spleen sections from day 0, 203 
1, 7 and 21–infected mice show blood vessels identified with anti-CD31 in blue and thrombi with 204 
anti-fibrin/fibrinogen in brown. Arrows identify individual thrombi. (B) Representative low power 205 
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images of spleen and liver sections stained for CD41 (platelets; blue) and fibrin/fibrinogen (brown) 206 
from mice infected for 24 hours via the i.v. route with 5x105 STm SL3261. The left hand graph shows 207 
the number of thrombi per spleen section for mice infected i.p. or i.v. The right hand graph shows the 208 
number of thrombi per section in the spleen and liver from these i.v. infected mice. (C) Representative 209 
low power images of spleen and liver sections stained for CD41 (platelets; blue) and fibrin/fibrinogen 210 
(brown) from mice infected for 24 hours with the virulent 105 STm SL1344 strain. The left hand 211 
graph shows the number of thrombi per spleen section for mice infected with SL3261 (attenuated) or 212 
SL1344 (virulent). The right hand graph shows the number of thrombi per section in the spleen and 213 
liver from mice infected with SL1344. (D) Representative scans at higher magnification of spleen 214 
sections (upper panels) and liver sections (lower panels) from WT mice at day 0, 1, 7 and 21 post-215 
infection with 5x105 STm SL3261. Sections are stained for fibrin/fibrinogen (brown) and CD41 216 
(blue). V=Vein, RP=Red Pulp, WP=White Pulp, T=Thrombus. (E) Quantification of numbers of 217 
thrombi per spleen section (left graph) and the proportion of section area covered by thrombi (right 218 
graph) at days 0, 1, 2, 7 and 21 after infection with 5x105 STm SL3261. Each point represents a single 219 
mouse (Data are combined from 3 independent experiments); *p<0.05, 1 way ANOVA. (F) Line 220 
graph showing the level of thrombosis in the spleen (black line) and the liver (grey line) over the first 221 
3 weeks of infection with 5x105 STm SL3261. The data are expressed as mean + S.E.M. from at least 222 
4 mice per group combined from 3 independent experiments. (G) Quantification of thrombi in spleen 223 
sections from PBS liposomes or clodronate liposome pre-treated mice, infected for 24 hours with 224 
5x105 STm SL3261. Combined data from 2 experiments with a total of 8 mice in each group. 225 
*p<0.05. 2-tailed non-parametric t test. N.D.=Not detected. 226 
Figure 2. Detection of bacteria within thrombi. Representative immunofluorescence 227 
photomicrographs of (A) spleens and (B) livers from WT mice infected with 5x105 STm SL3261 for 228 
0, 1, 7 and 21 days. (V=Vein, RP=Red Pulp, WP=White Pulp, T=Thrombus, MK=Megakaryocyte). 229 
Fibrin, blue; CD31, white; CD41, red and STm, green indicated with white arrows. For both (A) and 230 
(B) the second row shows a higher magnification image of the area identified by the white box. (C) 231 
and (D) Frequency of detecting 0, 1, 2 or ≥3 bacteria in thrombi in sections from spleens and livers 232 
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respectively, infected with 5x105 STm SL3261 for 0, 1, 7 or 21 days. (E) and (F) Line graphs showing 233 
the kinetics of thrombosis (black) and bacterial colonisation (gray) in spleens and livers respectively, 234 
from mice infected with 5x105 STm SL3261 for 0, 1, 2, 7 or 21 days. Data are expressed as mean + 235 
S.E.M. from 152 thrombi counted in spleens from day 1; 40 from day 7; and 18 from day 21-infected 236 
mice. In liver, 411 thrombi were counted for day 7 and 23 for day 21 after infection. In each case 237 
thrombi were counted from at least 4 mice per group and are combined from 3 independent 238 
experiments. CFU= Colony-forming unit. 239 
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